throbber
Paper No. __
`Filed: January 7, 2015
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`RANBAXY LABORATORIES LTD AND RANBAXY, INC.
`Petitioners,
`
`v.
`
`ADAMAS PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-00410
`Patent 8,362,085
`________________
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 35 U.S.C. §§ 311-319 AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ.
`
`
`
`
`
`

`
`Case IPR2015-00410
`Patent 8,362,085
`Patent Owner Mandatory Notices
`
`
`REAL PARTIES-IN-INTEREST
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(b)(1), the undersigned state
`
`that Adamas Pharmaceuticals, Inc. (“Adamas”), Forest Laboratories, LLC and
`
`Forest Laboratories Holdings, Ltd. (together, “Forest”) are the real parties-in-
`
`interest. Adamas is a corporation organized and existing under the laws of the
`
`State of Delaware, having a principal place of business at 1900 Powell Street, Suite
`
`750, Emeryville, California, 94608. Forest Laboratories, LLC is a limited liability
`
`company organized and existing under the laws of the State of Delaware, having a
`
`principal place of business at Morris Corporate Center III, 400 Interpace Parkway,
`
`Parsippany, New Jersey 07054. Forest Laboratories Holdings, Ltd. is an Irish
`
`corporation, having a principal place of business at Cumberland House, 1 Victoria
`
`Street, Hamilton HM11, Bermuda.
`
`Since the issuance of U.S. Patent No. 8,362,085 (the “’085 patent”) Adamas
`
`has been, and continues to be, the ’085 patent’s sole owner pursuant to the
`
`Assignment recorded with the United States Patent and Trademark Office on July
`
`17, 2012, at Reel 028569, Frame 0354. Forest is the exclusive licensee of the ’085
`
`patent with respect to commercializing pharmaceutical products containing
`
`memantine in the United States.
`
`
`
`
`
`

`
`Case IPR2015-00410
`Patent 8,362,085
`Patent Owner Mandatory Notices
`
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), the undersigned state that the ’085 patent
`
`is the subject of six, currently-pending litigations: Forest Laboratories, Inc. et al.
`
`v. Ranbaxy Inc. et al., 14-cv-686 (D. Del.); Forest Laboratories, Inc. et al. v. Teva
`
`Pharmaceuticals USA Inc. et al., 14-cv-121 (D. Del.); Forest Laboratories, Inc. et
`
`al. v. Apotex Corp. et al., 14-cv-200 (D. Del.); Forest Laboratories, Inc. et al. v.
`
`Amneal Pharmaceuticals LLC et al., 14-cv-508 (D. Del.); Forest Laboratories,
`
`LLC et al. v. Lupin Limited et al., 14-cv-1058 (D. Del.); and Forest Laboratories,
`
`LLC et al. v. Amerigen Pharmaceuticals Inc. et al., 14-cv-1271 (D. Del.).
`
`Additionally, the following issued U.S. patent and pending U.S. patent
`
`applications claim the benefit of the ’085 patent: U.S. Patent No. 8,598,233, issued
`
`on December 3, 2013, U.S. Patent Application No. 14/081,643, filed on November
`
`15, 2013, and U.S. Patent Application No. 14/339,599, filed on July 24, 2014.
`
`LEAD COUNSEL AND BACK-UP COUNSEL (37 C.F.R. § 42.8(b)(3))
`
`Lead Counsel:
`
`
`
`Peter J. Armenio, P.C. (Reg. No. 41,588)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: peterarmenio@quinnemanuel.com
`
`
`
`
`
`
`
`
`
`

`
`Case IPR2015-00410
`Patent 8,362,085
`Patent Owner Mandatory Notices
`
`
`
`
`
`
`
`
`Telephone: 212-849-7000
`
`
`
`
`
`Back-Up Counsel:
`
`Evangeline Shih (Reg. No. 50,170)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: evangelineshih@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`SERVICE INFORMATION
`
`Pursuant to 37 C.F.R. § 42.8(b)(4), please direct all correspondence to lead
`
`and back-up counsel at the above addresses. Patent Owner consents to email
`
`service at the above-specified email addresses.
`
`
`
`Date: January 7, 2015
`
`
`
` Respectfully submitted,
`
`By: /Peter J. Armenio, P.C. (Reg. No. 41,588)/
` Peter J. Armenio, P.C. (Reg. No. 41,588)
`Evangeline Shih (Reg. No. 50,170)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`peterarmenio@quinnemanuel.com
`
`

`
`Case IPR2015-00410
`Patent 8,362,085
`Patent Owner Mandatory Notices
`
`
`evangelineshih@quinnemanuel.com
`
`Attorneys for Adamas Pharmaceuticals,
`Inc., Forest Laboratories LLC and
`Forest Laboratories Holdings, Ltd.
`
`
`
`
`
`
`
`

`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`RANBAXY LABORATORIES LTD AND RANBAXY, INC.
`Petitioners,
`
`v.
`
`ADAMAS PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-00410
`Patent 8,362,085
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`

`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that
`
`PATENT OWNER’S MANDATORY NOTICES and the attached POWER OF
`
`ATTORNEY and 3.73(b) STATEMENT were served on January 7, 2015 by filing
`
`these documents through the Patent Review Processing System, as well as e-
`
`mailing copies to jbateman@kenyon.com and ali@kenyon.com.
`
`Date: January 7, 2015
`
` Respectfully submitted,
`
`By: /Peter J. Armenio, P.C. (Reg. No. 41,588)/
` Peter J. Armenio, P.C. (Reg. No. 41,588)
`Evangeline Shih (Reg. No. 50,170)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`peterarmenio@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`
`Attorneys for Adamas Pharmaceuticals,
`Inc., Forest Laboratories LLC and
`Forest Laboratories Holdings, Ltd.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket